Bio Techne
Biotechnology, 614 McKinley, Minneapolis, Minnesota, 55413, United States, 1001-5000 Employees
Phone Number: 80********
Who is BIO-TECHNE
Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, i...
Read More
- Headquarters: 614 McKinley, Minneapolis, Minnesota, 55413, United States
- Employees: 1001-5000
- Revenue: $1 Billion and Over
- CEO: Charles Kummeth
Industry: Biotechnology
SIC Code: 1541 | NAICS Code: 621511 | Show More
Does something look wrong? Fix it. | View contact records from BIO-TECHNE
Bio-Techne Org Chart and Mapping
Similar Companies to Bio-Techne
Boston Biochem
- 11-50
- $ 1 Million to 5 Million
ProteinSimple
- 51-200
- $ 250 Million to 500 Million
R&D Systems
- 1001-5000
- $ 250 Million to 500 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Bio-Techne
Answer: Bio-Techne's headquarters are located at 614 McKinley, Minneapolis, Minnesota, 55413, United States
Answer: Bio-Techne's phone number is 80********
Answer: Bio-Techne's official website is https://bio-techne.com
Answer: Bio-Techne's revenue is $1 Billion and Over
Answer: Bio-Techne's SIC: 1541
Answer: Bio-Techne's NAICS: 621511
Answer: Bio-Techne has 1001-5000 employees
Answer: Bio-Techne is in Biotechnology
Answer: Bio-Techne top competitors include: Boston Biochem , ProteinSimple , R&D Systems
Answer: Bio-Techne contact info: Phone number: 80******** Website: https://bio-techne.com
Answer: Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Technes portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls, and other reagents for OEM and clinical customers. Bio-Technes genomic tools include advanced tissue-based in situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand, as well as a portfolio of clinical molecular diagnostic oncology assays including the ExoDxProstate (IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Technes Diagnostics and Genomics Segment. Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $714 million in net sales in fiscal 2019 and has over 2,200 employees worldwide.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month